Cellectis (CLLS) Long-Term Investments (2015 - 2026)

Cellectis' Long-Term Investments history runs 12 years deep, the most recent figure standing at $185.7 million for Q1 2026.

• On a quarterly basis, Long-Term Investments rose 3428.37% year-over-year to $185.7 million in Q1 2026; TTM through Mar 2026 was $185.7 million, a 3428.37% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, down 98.05% from the prior year.
• Long-Term Investments improved to $185.7 million in Q1 2026 per CLLS's latest filing, from $5.1 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $260.3 million in Q4 2024 and bottomed at $5.1 million in Q4 2025.
• The 5-year median for Long-Term Investments is $13.0 million (2023), against an average of $61.3 million.
• Across the five-year window, Long-Term Investments sank 98.05% in 2025 and soared 3428.37% in 2026, its largest moves.
• Year by year, Long-Term Investments stood at $7.9 million in 2022, then decreased by 0.68% to $7.9 million in 2023, then jumped by 3214.73% to $260.3 million in 2024, then tumbled by 98.05% to $5.1 million in 2025, then surged by 3549.04% to $185.7 million in 2026.
• Per Business Quant, the three latest CLLS Long-Term Investments figures stand at $185.7 million (Q1 2026), $5.1 million (Q4 2025), and $35.7 million (Q3 2025).